Yahoo Web Search

Search results

  1. Sep 23, 2021 · Details. Transcript. September 23, 2021. Noubar Afeyan, cofounder and chair of Moderna Therapeutics and CEO of Flagship Pioneering, says that the breakthrough innovation behind the company’s ...

  2. Nov 15, 2021 · Afeyan, 59, is one of five billionaires associated with it, with an estimated $2.9 billion fortune (Bancel is another, worth some $7.5 billion).

  3. People also ask

  4. Aug 10, 2023 · Afeyan says he’d originally envisioned Moderna as a $100 billion company. (Its market capitalization topped $180 billion in 2021, after its vaccines rolled out; in early August, it stood at $41 ...

  5. Jun 29, 2023 · Noubar Afeyan became a billionaire backing Moderna Inc., the dark horse biotech firm that became a household name due to its lifesaving Covid vaccine. He just added to his fortune after another...

  6. Jan 6, 2021 · Noubar Afeyan at the Moderna IPO. Flagship Pioneering It was valued at $7.5 billion at the time. Afeyan owns over 2.1 million shares.

  7. Moderna has been in the news lately around their development of a COVID-19 vaccine. Back in 2019, HBS professor and Laboratory for Innovation Science at Harv...

    • 5K
    • Harvard Online
  8. Oct 11, 2021 · Neva Grant. In the field of bio-tech, it can take 10 years and millions of dollars to see if an experimental idea might turn into a life-saving treatment—if it ever does. Noubar Afeyan fully ...

  1. People also search for